However, NF-kB has been shown to be a promising target for therapeutic intervention in CLL cells [97], [98], and further functional experiments and especially in-vivo analyses should be performed to fully understand the mechanistic link between 13q14 and NF-kB in CLL. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.